
Brazil's securities regulator has ordered shareholder Centaurus to launch a tender offer for Oncoclínicas minority shares, in a case estimated at up to US$1.26 billion. The unanimous board vote reverses the regulator's own technical staff…
View original source — Rio Times ↗